Articles By Marcus Johnson

31. Researchers Link Biomarker To Cancer Drug Resistance 4/24/2014

    Researchers at the University of California, San Diego School of Medicine have announced the discovery of a biomarker named CD61. Biomarker CD61 is found on the surface of drug-resistant tumors, and researchers believe that it enhances the stem cell-like properties of cancer cells and prompts tumor metastasis.

32. Kala Pharmaceuticals Raises $23 Million For Eye Disease Trials 4/24/2014

    Kala Pharmaceuticals has raised $23 million in order to pay for new clinical trials for its eye drugs. The company expects to start four mid to late stage clinical trials in the next 8 months, according to Guillaume Pfefer, the company’s CEO.

33. Heart Metabolics Limited Raises $20 Million For Heart Disease Drug Trials 4/24/2014

    Heart Metabolics Limited, which is based out of Dublin, Ireland, has announced that it has raised $20 million for Phrase 3 clinical trials on a heart disease drug, perhexiline. The drug, perhexiline, is designed to treat hypertropic cardiomyopathy, which is a disease that can cause sudden death in athletes.

34. Questcor's Kidney Disease Drug Shows Potential 4/23/2014

    Questcor Pharmaceuticals has announced that its clinical study on the effectiveness of its kidney disease drug, Acthar Gel, has produced positive results. Acthar was tested on 20 patients with nephrotic syndrome due to idiopathic membranous nephropathy (iMN) at two major academic centers, Mayo Clinic and the University of Toronto. The researchers found that the drug was well tolerated by patients, and that it could potentially induce remission of proteinuria in patients suffering from nephrotic syndrome due to iMN.

35. Ground Fluor Pharmaceuticals Secures Funding For Isotope Development 4/21/2014

    Ground Fluor Pharmaceuticals, which is a medical technology startup based out of Lincoln, Nebraska, has secured funding from public and private sources.

36. FDA Approves GSK/Genmab Drug For Chronic Lymphocytic Leukemia 4/21/2014

    The Food and Drug Administration has approved Arzerra for the treatment of chronic lymphocytic leukemia in combination with chlorambucil, another chemotherapy drug produced by GlaxoSmithKline.

37. GSK Facing Criminal Investigation Following Bribery Allegations 4/16/2014

    Pharmaceutical giant GlaxoSmithKline is facing charges in Poland for allegedly bribing doctors.

38. US Jury Orders Takeda and Eli Lilly To Pay A Total Of $9 Billion 4/15/2014

    Takeda Pharmaceuticals and Eli Lilly were ordered by a Lafayette, LA  jury to pay a total of $9 billion in punitive damages after the jury found them guilty of hiding the cancer risks associated with their Actos diabetes drug.

39. pSivida Resubmits Application For Eye Disease Drug Iluvien 4/15/2014

    pSivida announced that the company is resubmitting an FDA drug application for their eye disease drug, Iluvien.

40. Idera Pharmaceuticals Says Experimental Psoriasis Drug Safe For B-Cell Lymphoma Treatment 4/14/2014

    In a company press release, Idera Pharmaceuticals stated that its experimental psoriasis drug, IMO-8400, was found to be safe and well tolerated in a skin disease study.